 Dalrada Financial Corp OTCQB:DFCO said due to the growing need for precision medicine, it is entering the global genomics market with the launch of its subsidiary Dalrada Healths product portfolio, Empower Genomics. The company said Empower is producing and providing a custom-labeled suite of tests, including pharmacogenomics PGx and testing analysis for alternative therapies such as nutraceuticals, nutritiondiet, and exercisefitness. 